Biotage AB | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
64.71 M |
Public Float |
- |
Biotage AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK2.62 |
Market Cap |
SEK7.02 B |
Shares Outstanding |
65.2 M |
Public Float |
51.74 M |
Address |
Vimpelgatan 5 Uppsala UP 753 18 Sweden |
Employees | - |
Website | http://www.biotage.com |
Updated | 07/08/2019 |
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products include equipment for chromatography and purification, organic synthesis, analytical sample preparation, evaporation and concentration, peptide synthesis, and custom projects. The company was founded by Pal Nyrén, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Björn Ekström in 1997 and is headquartered in Uppsala, Sweden. |